Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

Kate Middleton shared a rare update on her health. The Princess of Wales was diagnosed with cancer in March 2024, though most ...

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform ...

RECORD numbers of cancers are being diagnosed early when they are more curable, NHS figures show. Nearly six in ten of the 13 ...

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

IT was Christmas 2018, a time for family, friends and festive cheer. Among the millions of Brits celebrating was beloved TV ...

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Metastatic Colorectal Cancer.

Tevimbra is under clinical development by BeiGene and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC).

On New Year’s Eve, the much-loved BBC North West weather presenter received a worrying diagnosis of ovarian cancer. Just 10 ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...